Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases

Anti-tumour necrosis factor (TNF)-α agents have been increasingly used to treat patients affected by inflammatory bowel disease and dermatological and rheumatologic inflammatory disorders. However, the widening use of biologics is related to a new class of adverse events called paradoxical reactions...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopetuso, Loris Riccardo, Cuomo, Claudia, Mignini, Irene, Gasbarrini, Antonio, Papa, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179362/
https://www.ncbi.nlm.nih.gov/pubmed/37175894
http://dx.doi.org/10.3390/ijms24098187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179362/
https://www.ncbi.nlm.nih.gov/pubmed/37175894
http://dx.doi.org/10.3390/ijms24098187

Ejemplares similares